| Primary |
| Anaesthesia |
21.6% |
| Induction Of Anaesthesia |
10.8% |
| General Anaesthesia |
10.1% |
| Sedative Therapy |
10.1% |
| Sedation |
8.6% |
| Drug Use For Unknown Indication |
6.5% |
| Product Used For Unknown Indication |
5.0% |
| Electroconvulsive Therapy |
3.6% |
| Cushing's Syndrome |
2.9% |
| Endotracheal Intubation |
2.9% |
| Hypotonia |
2.9% |
| Induction And Maintenance Of Anaesthesia |
2.9% |
| Mean Arterial Pressure |
2.9% |
| Opiates |
1.4% |
| Pain |
1.4% |
| Pneumonia Staphylococcal |
1.4% |
| Resuscitation |
1.4% |
| Volume Blood Increased |
1.4% |
| Wada Test |
1.4% |
| Abdominal Pain Upper |
0.7% |
|
| Myoclonus |
16.4% |
| Drug Ineffective |
10.9% |
| Cardiac Arrest |
7.3% |
| Injection Site Phlebitis |
7.3% |
| Medication Error |
7.3% |
| Tachycardia |
7.3% |
| Grand Mal Convulsion |
5.5% |
| Ventricular Tachycardia |
5.5% |
| Vomiting |
5.5% |
| Bradycardia |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Product Quality Issue |
3.6% |
| Ventricular Fibrillation |
3.6% |
| Adrenal Suppression |
1.8% |
| Anaesthetic Complication Neurological |
1.8% |
| Anaphylactic Reaction |
1.8% |
| Central Venous Pressure Decreased |
1.8% |
| Cerebrovascular Accident |
1.8% |
| Death |
1.8% |
| Decreased Activity |
1.8% |
|
| Secondary |
| Anaesthesia |
21.8% |
| General Anaesthesia |
18.3% |
| Drug Use For Unknown Indication |
15.3% |
| Product Used For Unknown Indication |
10.8% |
| Induction Of Anaesthesia |
8.8% |
| Endotracheal Intubation |
4.0% |
| Major Depression |
3.8% |
| Pulmonary Hypertension |
3.3% |
| Sedation |
3.0% |
| Anaesthesia Procedure |
1.5% |
| Foetal Exposure Timing Unspecified |
1.3% |
| Induction And Maintenance Of Anaesthesia |
1.3% |
| Maintenance Of Anaesthesia |
1.3% |
| Antibiotic Prophylaxis |
1.0% |
| Cardiomyopathy |
1.0% |
| Depression |
1.0% |
| Ejection Fraction Decreased |
0.8% |
| Muscle Twitching |
0.8% |
| Pneumonia |
0.8% |
| Accidental Exposure To Product |
0.5% |
|
| Anaphylactic Shock |
10.5% |
| Cardiac Arrest |
8.8% |
| Blood Pressure Systolic Increased |
7.0% |
| Live Birth |
7.0% |
| Tachycardia |
7.0% |
| Urticaria |
7.0% |
| Ventricular Tachycardia |
7.0% |
| Blood Pressure Decreased |
5.3% |
| Hypotension |
5.3% |
| Toxic Skin Eruption |
5.3% |
| Cardiovascular Disorder |
3.5% |
| Death |
3.5% |
| Premature Baby |
3.5% |
| Renal Impairment |
3.5% |
| Respiratory Arrest |
3.5% |
| Terminal Insomnia |
3.5% |
| Vomiting |
3.5% |
| Agitation |
1.8% |
| Bradycardia |
1.8% |
| Bronchospasm |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
51.9% |
| Drug Use For Unknown Indication |
25.4% |
| Coronary Artery Bypass |
4.9% |
| Anaesthesia |
3.6% |
| Aortic Valve Replacement |
1.7% |
| Prophylaxis |
1.5% |
| Catheterisation Cardiac |
1.2% |
| Induction Of Anaesthesia |
1.2% |
| Hypertension |
1.2% |
| Supplementation Therapy |
1.0% |
| Sedation |
1.0% |
| Mitral Valve Replacement |
0.8% |
| Chronic Lymphocytic Leukaemia |
0.7% |
| Pain |
0.7% |
| General Anaesthesia |
0.6% |
| Thrombosis Prophylaxis |
0.6% |
| Mitral Valve Repair |
0.5% |
| Atrial Fibrillation |
0.5% |
| Myocardial Infarction |
0.5% |
| Pancreatitis |
0.5% |
|
| Pain |
10.8% |
| Injury |
10.5% |
| Renal Failure |
8.9% |
| Unevaluable Event |
8.0% |
| Anxiety |
6.8% |
| Fear |
5.2% |
| Sepsis |
4.9% |
| Stress |
4.9% |
| Anhedonia |
4.3% |
| Depression |
4.3% |
| Renal Failure Acute |
4.3% |
| Emotional Distress |
4.0% |
| Renal Injury |
3.7% |
| Vomiting |
3.7% |
| Renal Impairment |
3.4% |
| Vascular Pseudoaneurysm |
3.1% |
| Ventricular Fibrillation |
2.8% |
| Respiratory Failure |
2.2% |
| Serotonin Syndrome |
2.2% |
| Ventricular Tachycardia |
2.2% |
|
